Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUFINAMIDE, with a corresponding US DMF Number 26209.
Remarkably, this DMF maintains an Active status since its submission on October 23, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 24, 2013, and payment made on November 06, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II